SOPHiA GENETICS SA Shareholders Approve 2024 Financials
Ticker: SOPH · Form: 6-K · Filed: Jun 18, 2025 · CIK: 1840706
| Field | Detail |
|---|---|
| Company | Sophia Genetics SA (SOPH) |
| Form Type | 6-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, financials, reporting
Related Tickers: SOPH
TL;DR
SOPH shareholders rubber-stamped the 2024 financials at the AGM.
AI Summary
On June 18, 2025, SOPHiA GENETICS SA held its annual general meeting where shareholders approved the 2024 Management Report, Annual Financial Statements, and Consolidated Financial Statements. The company is a foreign private issuer filing under the 1934 Act.
Why It Matters
Shareholder approval of financial statements is a routine but necessary step for public companies, indicating transparency and compliance with reporting standards.
Risk Assessment
Risk Level: low — This filing is a routine report of annual general meeting results and financial statement approval, with no new material information or significant changes.
Key Players & Entities
- SOPHiA GENETICS SA (company) — Registrant
- June 18, 2025 (date) — Date of annual general meeting
- 2024 (date) — Financial year for approved statements
FAQ
What was the purpose of the June 18, 2025 filing?
The purpose was to report the final results of the agenda items voted on at SOPHiA GENETICS SA's annual general meeting held on June 18, 2025.
Which financial statements were approved by shareholders?
Shareholders approved the 2024 Management Report, the Annual Financial Statements, and the Consolidated Financial Statements for the financial year 2024.
Is SOPHiA GENETICS SA filing as a domestic or foreign issuer?
SOPHiA GENETICS SA is filing as a foreign private issuer.
Under which SEC Act is this report filed?
This report is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the principal executive office address of SOPHiA GENETICS SA?
The principal executive office is located at La Pièce 12 CH-1180 Rolle, Switzerland.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 18, 2025 regarding SOPHiA GENETICS SA (SOPH).